Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

218
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
218
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

277
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
277
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

235
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
235

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Deep learning based hair removal on ultraviolet-induced fluorescence dermatoscopy images.

Computer methods and programs in biomedicine·2026
Same author

Comparative evaluation of the Mayo Clinic Florida microdosimetric kinetic model and mMKM for carbon ion treatment planning: A matRad-based analysis.

Journal of applied clinical medical physics·2026
Same author

Impact of LET-modifying planning objectives on the optimization of mixed-modality proton-photon treatments.

Medical physics·2026
Same author

Trading robustness: A scenario-free approach to robust multi-criteria optimization for treatment planning.

Medical physics·2026
Same author

Resource sharing and open-source software in radiation oncology: From challenges to opportunities for community-wide benefit.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Dynamic changes in mean corpuscular volume could be integrated into longitudinal prediction frameworks for individualized risk assessment in the ICU setting: A retrospective study.

Science progress·2026

相关实验视频

Updated: Jan 16, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

通过GPU加速的FREDopt包,通过优化方法优化同时剂量和LETd质子辐射疗法计划.

Damian Borys1,2, Jan Gajewski2, Tobias Becher3,4,5

  • 1Silesian University of Technology, Department of Systems Biology and Engineering, Gliwice, Poland.

ArXiv
|October 3, 2025
PubMed
概括

新的GPU加速软件FREDopt优化了剂量和剂量平均线性能量转移 (LETd) 的质子疗法计划. 它显著降低了风险器官中的LETd,同时保持了目标覆盖率,提供了临床潜力.

关键词:
寻求可行性,寻求可行性.线性能量转移 (LET) 是指线性能量转移.质子疗法是一种质子疗法.辐射治疗疗法 辐射治疗疗法优越化的优越化治疗计划优化治疗计划优化

更多相关视频

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.8K

相关实验视频

Last Updated: Jan 16, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.1K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.8K

科学领域:

  • 医学物理 医学物理
  • 计算生物学 计算生物学
  • 放射治疗研究 放射治疗研究

背景情况:

  • 质子疗法提供精确的剂量传递,但优化剂量和线性能量转移 (LET) 仍然具有挑战性.
  • 改善治疗计划系统对于最大限度地提高治疗效益和最小化质子疗法的副作用至关重要.

研究的目的:

  • 推出FREDopt,一个开源的,GPU加速的软件,用于在强度调制质子疗法 (IMPT) 中同时优化质子剂量和剂量平均的LET (LETd).
  • 评估FREDopt在降低风险器官 (OAR) 中剂量和LETd的有效性,同时保持目标剂量一致性.

主要方法:

  • FREDopt是用Python开发的,使用CuPy进行GPU加速,并集成快速的蒙特卡洛 (MC) 模拟.
  • 使用可行性搜索算法的新优化方法,有效地找到最佳的治疗计划.
  • 该软件的性能在临床患者治疗计划上得到验证,比较了预优化和再优化结果.

主要成果:

  • 使用FREDopt同时优化剂量和LETd,导致LETd和OAR中剂量和LETd的乘积显著减少.
  • 在重新优化过程中,成功地保持了目标剂量符合性.
  • 计算时间从14分钟到50分钟不等,这表明它适合临床和研究使用.

结论:

  • 在IMPT中,FREDopt提供了一种高效和有效的解决方案,用于同时优化剂量和LETd.
  • 该软件的开源性质和GPU加速性促进了进一步的开发和临床采用.
  • 这种方法有望提高质子疗法治疗效率和患者的治疗结果.